ArticleSAGE open medical case reports2026
Polymorphic eruption of pregnancy successfully treated with dupilumab in the postpartum period: A case report.
Article in SAGE open medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polymorphic eruption of pregnancy predominantly occurs during the last month of pregnancy or the immediate postpartum period. Dupilumab, an IgG4 monoclonal antibody, has been utilized in pregnancy and lactation. A 34-year-old gravida 2 para 1 female, on postoperative day 2 following a Cesarean section, presented with pruritic erythematous urticoid papules coalescing into plaques on the abdomen, bilateral arms, legs, and feet, suggestive of polymorphic eruption of pregnancy. A punch biopsy ruled out gestational pemphigoid. Prednisone was contraindicated given her gestational diabetes and gestational hypertension. Dupilumab was administered with betamethasone valerate ointment followed by transition to roflumilast cream. At 6-week follow-up, the skin was cleared of the rash. This case highlights a new potential utility for dupilumab in polymorphic eruption of pregnancy and may represent an alternative to oral steroids in severe or refractory disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.